Read the history in context
Records, not a safety rating.
Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.
View source coverage →Severity Breakdown
Class I — Serious
0Class II — Moderate
1Class III — Low Risk
1Categories
MEDICATION
Recall Timeline
Class IIIFDAAug 19, 2026
Chiesi USA — Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01 Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Track Chiesi USA recalls automatically
Get an alert when a matching Chiesi USA recall turns up.
Start Free Trial